The Anti-Mi-2 Antibody (M12) test detects autoantibodies linked to inflammatory muscle diseases (idiopathic inflammatory myopathies), especially dermatomyositis (DM), indicating a specific type with classic skin signs (heliotrope rash, V/shawl sign) and good response to steroids, lower risk of lung issues, but potentially higher muscle inflammation initially. This blood test uses methods like line-blot techniques to find these antibodies, which target the Mi-2 protein in the NuRD complex, helping diagnose the specific autoimmune profile and predict better outcomes